Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development.
暂无分享,去创建一个
Ramanan Laxminarayan | Francois Nosten | Nicholas J White | N. Ford | W. Kilama | F. Binka | F. Nosten | P. Olliaro | N. White | P. Guérin | R. Laxminarayan | Nathan Ford | Piero Olliaro | P. Druilhe | Philippe J Guerin | Fred Binka | Pierre Druilhe | Wen L Kilama
[1] A. Mills,et al. The Gambian National Impregnated Bednet Programme: costs, consequences and net cost-effectiveness. , 1998, Social science & medicine.
[2] Kenneth J Rothman,et al. Fake antimalaria drugs in Cambodia. , 2001, Lancet.
[3] J. Breman,et al. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. , 2001, The American journal of tropical medicine and hygiene.
[4] C. Goodman,et al. Cost-effectiveness of malaria control in sub-Saharan Africa , 1999, The Lancet.
[5] E. Lagarde,et al. Impact of chloroquine resistance on malaria mortality. , 1998, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[6] M. Tanner,et al. Clinical trials of malaria vaccines: progress and prospects. , 1997, Advances in parasitology.
[7] J. Trape. The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.
[8] A. Kroeger,et al. Insecticide-treated materials for malaria control in Latin America: to use or not to use? , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[9] J. Palensky,et al. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. , 2001, The Journal of infectious diseases.
[10] S. Bounyasong. Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women. , 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[11] R. Steketee,et al. Risk factors for anemia in young children in rural Malawi. , 1994, American Journal of Tropical Medicine and Hygiene.
[12] C. Maung,et al. Clinical diagnosis of malaria on the Thai-Myanmar border. , 2001, The Yale journal of biology and medicine.
[13] S. Benatar. The HIV/AIDS pandemic: a sign of instability in a complex global system. , 2002, The Journal of medicine and philosophy.
[14] Alan D. Lopez,et al. Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.
[15] E. Einterz,et al. Fever in Africa: do patients know when they are hot? , 1997, The Lancet.
[16] D. Kyle,et al. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand , 1996, The Lancet.
[17] P. Olliaro,et al. Drug development output from 1975 to 1996: what proportion for tropical diseases? , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[18] B. Greenwood. The epidemiology of malaria. , 1997, Annals of tropical medicine and parasitology.
[19] B. Greenwood,et al. Malaria in 2002 , 2002, Nature.
[20] R. Snow,et al. Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. , 2001, The American journal of tropical medicine and hygiene.
[21] J. Breman,et al. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. , 2001, The American journal of tropical medicine and hygiene.
[22] H. Barennes,et al. [Intrarectal administration of quinine: an early treatment for severe malaria in children?]. , 2001, Sante.
[23] Joe D. Cohen,et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.
[24] K. Bojang,et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial , 2000, The Lancet.
[25] K. Marsh,et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study , 2000, The Lancet.
[26] J. Utzinger,et al. Efficacy and cost‐effectiveness of environmental management for malaria control , 2001, Tropical medicine & international health : TM & IH.
[27] Stephane Proux,et al. Fake artesunate in southeast Asia , 2001, The Lancet.
[28] F. Cohen,et al. The Impact of Whole Genome Sequence Data on Drug Discovery—A Malaria Case Study , 2001, Molecular medicine.
[29] Els Torreele,et al. Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.
[30] D. Kwiatkowski,et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. , 1996, The Journal of infectious diseases.
[31] N. White,et al. Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[32] K. Bojang. The diagnosis of Plasmodium falciparum infection in Gambian children, by field staff using the rapid, manual, ParaSight-F test. , 1999, Annals of tropical medicine and parasitology.
[33] P. Newton,et al. Malaria: new developments in treatment and prevention. , 1999, Annual review of medicine.
[34] F. Cobelens,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[35] Richard N. Price,et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.
[36] P. Olliaro,et al. Averting a malaria disaster , 1999, The Lancet.
[37] S. Hoffman,et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. , 1998, The Journal of infectious diseases.
[38] S. Mharakurwa,et al. Diagnostic performance of two antigen capture tests for the diagnosis of Plasmodium falciparum malaria in Zimbabwe. , 1999, Central African Journal of Medicine.
[39] B. F. Hall,et al. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. , 1999, Vaccine.
[40] N. White,et al. Editorial: Antimalarial drug resistance and mortality in falciparum malaria , 1999, Tropical medicine & international health : TM & IH.
[41] D. Kaslow,et al. Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys , 1995, Molecular medicine.
[42] D. Wirth,et al. Malaria, the submerged disease. , 1996, JAMA.
[43] J. Sachs,et al. The economic and social burden of malaria , 2002, Nature.
[44] I. Bygbjerg,et al. Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): relevance of laboratory support from the rapid immunochromatographic tests of ICT Malaria P.f/P.v and OptiMal. , 2001, Annals of tropical medicine and parasitology.
[45] R. Price,et al. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[46] L. BenMohamed,et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3 , 2000, Nature Medicine.
[47] K. Mendis,et al. The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.
[48] Peter E. Hilsenrath,et al. The World Health Report 2000 , 2002 .
[49] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[50] C. Lengeler,et al. Insecticide-treated bed nets and curtains for preventing malaria. , 2004, The Cochrane database of systematic reviews.
[51] J. Simpson,et al. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[52] B. Brabin,et al. An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy. , 1991, International journal of epidemiology.
[53] Pedro Romero,et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria , 1988, Nature.
[54] N. White,et al. Delaying antimalarial drug resistance with combination chemotherapy. , 1999, Parassitologia.
[55] C. Drakeley,et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.
[56] P. Olliaro,et al. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[57] L. Loutan,et al. Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[58] N. Rooijen,et al. Human Malaria in Immunocompromised Mice An in Vivo Model to Study Defense Mechanisms against Plasmodium falciparum , 2000 .
[59] K. Mendis,et al. Malaria transmission-blocking vaccines—how can their development be supported? , 2000, Nature Medicine.
[60] P. Bloland,et al. Making malaria-treatment policy in the face of drug resistance. , 1999, Annals of tropical medicine and parasitology.
[61] J. Sachs,et al. The economic burden of malaria. , 2001, The American journal of tropical medicine and hygiene.
[62] H. Wolf,et al. Malaria and Growth , 1999 .
[63] U. d’Alessandro,et al. Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. , 2000, Parasitology today.
[64] D. Conway,et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.
[65] F. Nosten,et al. Short communication: Paracheck‐Pf®: a new, inexpensive and reliable rapid test for P. falciparum malaria , 2001, Tropical medicine & international health : TM & IH.
[66] Irwin W. Sherman,et al. Malaria : parasite biology, pathogenesis, and protection , 1998 .
[67] J. Breman,et al. The intolerable burden of malaria: a new look at the numbers. , 2001, The American journal of tropical medicine and hygiene.
[68] T. Richie,et al. Progress and challenges for malaria vaccines , 2002, Nature.
[69] A. Saul,et al. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. , 2002, The Journal of infectious diseases.
[70] R. Steffen,et al. MalaQuick versus ParaSight F as a diagnostic aid in travellers' malaria. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[71] John Luke Gallup,et al. Geography and Economic Development , 1998 .
[72] J. E. Hyde,et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? , 2001, Trends in parasitology.
[73] T. Mutabingwa. Malaria and pregnancy: epidemiology, pathophysiology and control options. , 1994, Acta tropica.
[74] J. Derisi,et al. DNA microarrays for malaria. , 2002, Trends in parasitology.
[75] P. Kazembe,et al. A study of the consequences of malarial infection in pregnant women and their infants. , 1993, Parassitologia.
[76] P. Olliaro,et al. Mode of action and mechanisms of resistance for antimalarial drugs. , 2001, Pharmacology & therapeutics.
[77] P. Chiodini. Non-microscopic methods for diagnosis of malaria , 1998, The Lancet.
[78] C. Lengeler. Insecticide-treated bednets and curtains for preventing malaria. , 2000, The Cochrane database of systematic reviews.
[79] Q. Cheng,et al. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. , 2000, Vaccine.
[80] L. Chitsulo,et al. Clinical algorithm for treatment of Plasmodium falciparum malaria in children , 1996, The Lancet.
[81] D. Kyle,et al. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[82] K. Marsh. Malaria disaster in Africa , 1998, The Lancet.
[83] J. Rozendaal. Fake antimalaia drugs in Cambodia , 2001, The Lancet.
[84] J J Picq,et al. [Epidemiology of malaria]. , 1983, Soins. Pathologie tropicale.
[85] C. Goodman,et al. Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. , 2001, Health economics.
[86] C. Swisher. Combination therapy of malaria. , 1969, JAMA.
[87] H. Webster,et al. Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers. , 1994, Vaccine.
[88] C. Menéndez,et al. The burden of malaria in pregnancy in malaria-endemic areas. , 2001, The American journal of tropical medicine and hygiene.
[89] P. Winstanley,et al. Modern chemotherapeutic options for malaria. , 2001, The Lancet. Infectious diseases.
[90] R. Steketee,et al. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. , 1993, The Journal of infectious diseases.
[91] Thomas A. Smith,et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. , 2002, The Journal of infectious diseases.
[92] Gina Brown,et al. Implementation of the global malaria control strategy: World Health Organization. Technical Report Series 839. World Health Organization, Switzerland, 1993. 57 + v pp., Sw. fr. 10.00 — Developing Countries Sw. fr. 7.00. ISBN 92-4-120839-2 , 1994 .
[93] P. Chiodini,et al. Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples. , 1999, The American journal of tropical medicine and hygiene.
[94] A. Thomas,et al. Immunization with Parasite-Derived Apical Membrane Antigen 1 or Passive Immunization with a Specific Monoclonal Antibody Protects BALB/c Mice against Lethal Plasmodium yoelii yoeliiYM Blood-Stage Infection , 2000, Infection and Immunity.
[95] J. Rozendaal. Fake antimalaria drugs in Cambodia [letter] , 2001 .
[96] K. Bojang,et al. An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up. , 1998, Vaccine.